1. Home
  2. HZO vs KROS Comparison

HZO vs KROS Comparison

Compare HZO & KROS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo MarineMax Inc.  (FL)

HZO

MarineMax Inc. (FL)

HOLD

Current Price

$28.78

Market Cap

624.7M

ML Signal

HOLD

Logo Keros Therapeutics Inc.

KROS

Keros Therapeutics Inc.

HOLD

Current Price

$11.73

Market Cap

584.9M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
HZO
KROS
Founded
1998
2015
Country
United States
United States
Employees
N/A
N/A
Industry
Auto & Home Supply Stores
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
624.7M
584.9M
IPO Year
1998
2020

Fundamental Metrics

Financial Performance
Metric
HZO
KROS
Price
$28.78
$11.73
Analyst Decision
Strong Buy
Buy
Analyst Count
3
7
Target Price
$30.00
$21.86
AVG Volume (30 Days)
244.5K
397.0K
Earning Date
04-23-2026
05-05-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
146.00
EPS
N/A
2.30
Revenue
$2,309,288,000.00
$243,864,000.00
Revenue This Year
$3.84
N/A
Revenue Next Year
$4.21
$2,751.79
P/E Ratio
N/A
$5.10
Revenue Growth
N/A
N/A
52 Week Low
$17.74
$10.42
52 Week High
$32.00
$22.55

Technical Indicators

Market Signals
Indicator
HZO
KROS
Relative Strength Index (RSI) 60.01 45.61
Support Level $24.41 $10.45
Resistance Level $29.28 $12.65
Average True Range (ATR) 1.35 0.55
MACD 0.30 0.17
Stochastic Oscillator 79.09 55.83

Price Performance

Historical Comparison
HZO
KROS

About HZO MarineMax Inc. (FL)

MarineMax Inc is a United-States-based company that sells new and used recreational boats under premium brands, and related marine products, like engines, parts, and accessories. The company is also engaged in other businesses, including providing services of repair, maintenance, and storage; managing related boat financing, insurance, and others; offering brokerage sales of boats and yachts; and operating a yacht charter business. The reportable segments of the company are Retail Operations and Product Manufacturing. The Retail Operations segment generates the majority of the company's revenue. The sale of new and used boats accounts for the majority of the company's total revenue. It serves customers across the U.S and international market.

About KROS Keros Therapeutics Inc.

Keros Therapeutics Inc is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of novel treatments for patients suffering from hematological, pulmonary, and cardiovascular disorders with high unmet medical needs. The company's protein therapeutic product candidate, KER-050, is being developed for the treatment of low blood cells counts, or cytopenias, including anemia and thrombocytopenia, in patients with myelodysplastic syndromes, or MDS, and in patients with myelofibrosis.

Share on Social Networks: